Poland· PL-100413992
Belogent
A betamethason und antibiotika product containing betamethasonum + gentamicinum, registered in Poland by Pharmapoint SA. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Betamethason und antibiotika is registered in 9 of 19 countries.
Countries holding a registration under ATC D07CC01 (betamethason und antibiotika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Betamethason und antibiotika · ATC D07CC01
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Betamethasonum + Gentamicinum
- Manufacturer
- Pharmapoint SA
- Country
- Poland (PL)
- ATC code
- D07CC01
- ATC class
- Betamethason und Antibiotika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991390594
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Betamethason und antibiotika in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCELESTODERM 1 mg/g + 1 mg/g CREMAOrganon Salud S.L.
- SwitzerlandDiprogenta
- CanadaTOPAGENINTERVET CANADA CORP
- GermanyDiprogentaOrganonhealthcare Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Diprogenta
- Bulgaria · Бетадерм, Бетазонгент
- Czechia · Belogent
- Germany · Diprogenta
- Spain · Diprogenta
- Greece · Propiogenta
- Croatia · Belogent, Diprogenta
- Italy · Egerian, Fidagenbeta
- Portugal · Diprogenta, Epione
- Romania · Diprogenta
- Slovenia · Diprogenta
- Slovakia · Belogent
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc705f3b-da76-4c53-b65d-8831ef165d88 GET /v1/drugs/dc705f3b-da76-4c53-b65d-8831ef165d88?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(0,5 mg + 1 mg)/g",
"packaging": "05909991390594 ¦ Rp ¦ 130674\n1 tuba 30 g",
"substance": "Betamethasonum 0.5 mg/g + Gentamicinum 1 mg/g",
"common_name": "Betamethasonum + Gentamicinum",
"pl_product_id": "100413992",
"pozwolenie_nr": "3/19",
"auth_procedure": "IR",
"authorisation_validity": "2024-01-08"
}See everything about betamethason und antibiotika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.